GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genomics BioSci & Tech Co Ltd (ROCO:4195) » Definitions » Marketable Securities

Genomics BioSci & Tech Co (ROCO:4195) Marketable Securities : NT$87.9 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Genomics BioSci & Tech Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Genomics BioSci & Tech Co's Marketable Securities for the quarter that ended in Dec. 2024 was NT$87.9 Mil.

Genomics BioSci & Tech Co's annual Marketable Securities stayed the same from Dec. 2022 (NT$12.0 Mil) to Dec. 2023 (NT$12.0 Mil) but then increased from Dec. 2023 (NT$12.0 Mil) to Dec. 2024 (NT$87.9 Mil).


Genomics BioSci & Tech Co Marketable Securities Historical Data

The historical data trend for Genomics BioSci & Tech Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomics BioSci & Tech Co Marketable Securities Chart

Genomics BioSci & Tech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 106.00 12.00 12.00 12.00 87.94

Genomics BioSci & Tech Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.00 12.00 12.00 18.50 87.94

Genomics BioSci & Tech Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Genomics BioSci & Tech Co  (ROCO:4195) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Genomics BioSci & Tech Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Genomics BioSci & Tech Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomics BioSci & Tech Co Business Description

Traded in Other Exchanges
N/A
Address
14th Floor, Number 100, Xintai 5th Road, Sec 1, Xizhi District, New Taipei City, Taipei, TWN
Genomics BioSci & Tech Co Ltd is a Taiwan based commercial genome sequencing company formed to develop medical genetic testing. The services of the company include Sanger sequence service, Synthesis Service and Genomic Service.

Genomics BioSci & Tech Co Headlines

No Headlines